drugset
drugset / Trial / NCT06135948

Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism

NCT06135948 ↗

Phase 4 Completed 103 enrolled Emirates Health Services (EHS) University of Sharjah · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The study aims to compare the mean change in Thyroid Stimulating Hormone (TSH) levels among patients with hypothyroidism treated with an increased dose of L-thyroxine (treatment group) versus standard/regular dose of L-thyroxine (control group) during the month of Ramadan.

Timeline

Start
2022-03-15
Primary completion
2022-06-15
Completion
2022-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Levothyroxine Other / unclassified 25 ug —

Indications

thyroid hormone metabolism, abnormal